43 recruiting, 42 completed, 17 unknown, 15 active not recruiting. 67 Phase 2, 37 Phase 1, 18 Not applicable, 8 Early Phase 1, 7 Phase 3.
Follow Surgical Resection: new trials by email Literature Review of Surgical Resection trials Research Report on Surgical Resection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma | Phase 1 | Not yet recruiting | City of Hope Medical Center | 24 | 2027-02-17 | 2026-08-27 |
| Study of Robotic Assisted/Image Guided Electromagnetic Navigation Bronchoscopic Therapies and Surgery in Stage IA NSCLC Bronchoscopic Microwave Ablation, Surgical Resection - Stage IA NSCLC | Phase 2 | Not yet recruiting | Chinese University of Hong Kong | 292 | 2026-11-01 | 2026-10-21 |
| Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma Surgical resection, Preoperative RT - Adrenocortical Carcinoma (ACC), Recurrent Adrenocortical Carcinoma (ACC) | Phase 1 | Recruiting | National Cancer Institute (NCI) | 32 | 2026-10-28 | 2026-10-23 |
| A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. SRN-101, Blood Specimen Collection, Surgical Resection - Recurrent High-Grade Gliomas, Brain Neoplasm | Phase 1 | Not yet recruiting | Nicholas Butowski | 6 | 2026-10-15 | 2026-10-08 |
| Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With Surgical Microwave Ablation Assisted by Diaphragm Hydrodissection, Surgical Resection - Hepatocellular Carcinoma (HCC) | Not yet recruiting | The First Hospital of Jilin University | 200 | 2026-10-01 | 2026-09-11 | |
| Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and Surgical Resection for Subcapsular Hepatocellular Carcinoma No-touch Microwave Ablation, Tumor-puncture Microwave Ablation, Surgical Resection - Hepatocellular Carcinoma (HCC) | Not yet recruiting | The First Hospital of Jilin University | 180 | 2026-10-01 | 2026-08-05 | |
| Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma Surgical Resection, Stereotactic Body Radiation Therapy (SBRT), Atezolizumab - Osteosarcoma, Pulmonary Recurrence of Osteosarcoma | Phase 1 | Recruiting | Emory University | 12 | 2026-10-01 | 2026-09-30 |
| Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver Mutations Surgical Resection - Lung Cancer (NSCLC) | Phase 2 | Not yet recruiting | Shanghai Zhongshan Hospital | 190 | 2026-09-20 | 2026-09-21 |
| NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC Short-Course Radiotherapy, PD-1 monoclonal antibody, mFOLFOX6 regimen - Rectal Adenocarcinoma, High-Risk Cancer | Phase 2 | Not yet recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 100 | 2026-09-01 | 2026-08-14 |
| A Study of Stereotactic Radiosurgery (SRS) in People With Brain Cancer Having Tumor Resection Surgery Stereotactic Radiosurgery, Surgical Resection - Brain Metastasases | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 50 | 2026-08-28 | 2026-09-09 |
| Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial Electronic Health Record Review, Fluorescence Imaging, Fluorescence-Guided Surgery - High Grade Sarcoma, Sarcoma | Phase 2 | Recruiting | City of Hope Medical Center | 22 | 2026-08-14 | 2026-10-16 |
| RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer RiMO-301, Pembrolizumab, Radiation - Head and Neck Cancer, Head Cancer | Phase 2 | Not yet recruiting | University of Illinois at Chicago | 20 | 2026-08-01 | 2026-07-29 |
| A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Rhabdomyosarcoma | Phase 3 | Recruiting | Children's Oncology Group | 342 | 2026-07-14 | 2026-08-25 |
| Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas Autologous Anti-EGFR/Anti-IL13Ralpha2 CAR T-cells, Biopsy Procedure, Biospecimen Collection - Recurrent Astrocytoma, IDH-Mutant, Grade 4, Recurrent Glioblastoma, IDH-Wildtype | Phase 1 | Recruiting | City of Hope Medical Center | 24 | 2026-05-26 | 2026-10-23 |
| SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC Short-Course Radiotherapy, PD-1 monoclonal antibody, mFOLFOX6 regimen - Rectal Adenocarcinoma, High-Risk Cancer | Phase 3 | Recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 204 | 2026-05-20 | 2026-07-01 |
| Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma Metformin, Planned Surgical Resection, Magnetic Resonance Imaging (MRI) - Posterior Fossa Ependymal Tumor | Phase 2 | Recruiting | University of California, San Francisco | 30 | 2026-05-05 | 2026-10-20 |
| Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors Entrectinib, Cyclophosphamide, Etoposide - High Grade Glioma, CNS Tumor | Phase 2 | Recruiting | St. Jude Children's Research Hospital | 52 | 2026-05-01 | 2026-05-13 |
| Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma Surgical resection - Adenocarcinoma of the Pancreas | Not applicable | Recruiting | The University of Texas Health Science Center at San Antonio | 40 | 2026-03-02 | 2026-04-14 |
| Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular Carcinoma Surgical Resection, Maintenance Therapy Group - HCC - Hepatocellular Carcinoma, Watch & Wait | Recruiting | West China Hospital | 100 | 2026-03-01 | 2026-10-02 | |
| Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas XRD-0394, Radiation Therapy, Surgical Resection - High-Grade Glioma | Early Phase 1 | Recruiting | NYU Langone Health | 39 | 2025-11-05 | 2026-01-02 |
Showing 20 of 149. Sign in to see all of them.
Squamous Cell Carcinoma of Head and Neck (14) · Glioblastoma (11) · Rectal Neoplasms (11) · Brain Neoplasms (8) · Carcinoma, Hepatocellular (8) · Carcinoma, Non-Small-Cell Lung (7) · Colorectal Neoplasms (7) · Glioma (7) · Head and Neck Neoplasms (6) · Pancreatic Neoplasms (6) · Breast Neoplasms (5) · Melanoma (5) · Gliosarcoma (4) · Lung Neoplasms (4) · Sarcoma (4)
M.D. Anderson Cancer Center (10) · St. Jude Children's Research Hospital (8) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (7) · City of Hope Medical Center (5) · National Cancer Institute (NCI) (4) · Providence Health & Services (4) · Sixth Affiliated Hospital, Sun Yat-sen University (4) · Fudan University (3) · Mayo Clinic (3) · Memorial Sloan Kettering Cancer Center (3) · Northwestern University (3) · Royal Marsden NHS Foundation Trust (3) · UNC Lineberger Comprehensive Cancer Center (3) · University of California, San Francisco (3) · Beijing Tsinghua Chang Gung Hospital (2)
United States (83) · China (26) · Canada (8) · Australia (3) · South Korea (3) · France (2) · Netherlands (2) · Singapore (2) · Spain (2) · United Kingdom (2) · Belgium (1) · Brazil (1) · Egypt (1) · Germany (1) · Hong Kong (1)
Behnam Badie (2) · David Cunningham (2) · Nicholas Butowski, MD (2) · Song Fan, Doctor (2) · Abraham Wu, MD (1) · Aditi Bagchi, MD, PhD (1) · Agnieszka Fronczek, MD (1) · Aiwu R He, MD (1) · Alberto Pappo, MD (1) · Amar Gajjar, MD (1) · Ameen Salahudeen, MD, PhD (1) · Andrew Sloan, MD (1) · Andrew Wang, MD (1) · Anna Brzozowska, MD, PhD (1)
PMID 18222230, PMID 19008992, PMID 19525947, PMID 20106720, PMID 21752720, PMID 21774104, PMID 24139613, PMID 26834058, PMID 27784746, PMID 27821144, PMID 30111304, PMID 30344100, PMID 30858085, PMID 30860945, PMID 31558424, PMID 32221013, PMID 33594075, PMID 33963014, PMID 34670228, PMID 34871104, PMID 35070367, PMID 35399240, PMID 35483358, PMID 35837200, PMID 35866376, PMID 36652155, PMID 36880949, PMID 37166053, PMID 37312079, PMID 37365665, PMID 38350888, PMID 38781043, PMID 38964315, PMID 39402027, PMID 39812961, PMID 39848272, PMID 40255171, PMID 40389098, PMID 40855191, PMID 40858956, PMID 41177142, PMID 41213248, PMID 41800228, PMID 41879728, PMID 42064641, PMID 42502358
P30CA033572 (5), P30CA060553 (3), U10CA180886 (2), 2014 (1), 2018 (1), P30CA012197 (1), P30CA014089 (1), P30CA015704 (1), P30CA016086 (1), P30CA022453 (1), P30CA093373 (1), P30CA138292 (1), P50CA211015 (1), R01CA269950 (1), R01EB033008 (1)